From February 5, 2024 to March 31, 2024, the company has repurchased 2,070,000 shares, representing 1.08% for CNY 12.98 million. With this, the company has completed the repurchase of 2,070,000 shares, representing 1.08% for CNY 12.98 million under the buyback announced on February 6, 2024.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.43 CNY | -2.24% | -6.89% | -33.00% |
1st Jan change | Capi. | |
---|---|---|
-33.00% | 199M | |
-1.47% | 9.52B | |
-1.16% | 1.48B | |
-3.37% | 1.46B | |
-11.18% | 1.17B | |
-16.19% | 872M | |
-1.48% | 469M | |
+2.60% | 437M | |
-21.37% | 347M | |
-3.43% | 213M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Tranche Update on Thalys Medical Technology Group Corporation's Equity Buyback Plan announced on February 6, 2024.